{"id":14196,"date":"2016-09-19T19:24:45","date_gmt":"2016-09-19T23:24:45","guid":{"rendered":"http:\/\/goldstocksforex.com\/?p=14196"},"modified":"2016-09-19T19:24:45","modified_gmt":"2016-09-19T23:24:45","slug":"bob-doll-equities-appear-more-attractive-than-other-asset-classes-nuveen","status":"publish","type":"post","link":"https:\/\/thepatientinvestor.com\/index.php\/2016\/09\/19\/bob-doll-equities-appear-more-attractive-than-other-asset-classes-nuveen\/","title":{"rendered":"Bob Doll: Equities Appear More Attractive than Other Asset Classes | Nuveen"},"content":{"rendered":"<p>From Bob Doll&#8217;s weekly newsletter:<\/p>\n<blockquote><p>The strong patch of summer U.S. economic data may have ended. Following weak Institute for Supply Management readings in previous weeks, August retail sales declined 0.3%. This marks the first pullback since March, and bears watching for a broader downtrend into September&#8230;..<\/p>\n<p>Corporate earnings expectations are climbing slowly. Following a modest second quarter improvement, analyst expectations for future quarters have climbed in recent weeks&#8230;..<\/p>\n<p>Equities may continue to climb in 2016, based on historical trends. Strategy group Fundstrat shows that since 1940, when stock prices increased more than 5% by mid-September, 87% of the time they rallied further in the last three-and-a-half months of the year. As of Friday\u2019s close on September 16, the S&amp;P 500 Index is up 6.3%&#8230;.<\/p><\/blockquote>\n<p>As you can see from Bob&#8217;s commentary, there seems to be a divergence between economic data (retail sales in this case) and technicals which tend to be more focused on the earnings expectations. I have seen something similar.<\/p>\n<p>Retail sales have fallen in July\/August but of greater concern is the longer-term down-trend. Continued growth below core CPI would warn of a contraction in real terms.<\/p>\n<p><img data-recalc-dims=\"1\" decoding=\"async\" class=\"aligncenter\" title=\"Retail Sales ex Motor Vehicles &amp; Parts\" alt=\"Retail Sales ex Motor Vehicles &amp; Parts\" src=\"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2016\/09\/2016-09-20-retail.png?w=525&#038;ssl=1\" \/><\/p>\n<p>Light Vehicle Sales are also below trend, reinforcing the down-turn in consumer outlook.<\/p>\n<p><img data-recalc-dims=\"1\" decoding=\"async\" class=\"aligncenter\" title=\"Light Vehicle Sales\" alt=\"Light Vehicle Sales\" src=\"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2016\/09\/2016-09-20-lightvehicles.png?w=525&#038;ssl=1\" \/><\/p>\n<p>The decline in sales is reinforced by the decline in growth of average weekly earnings (all employees).<\/p>\n<p><img data-recalc-dims=\"1\" decoding=\"async\" class=\"aligncenter\" title=\"Weekly Earnings - All Employees\" alt=\"Weekly Earnings - All Employees\" src=\"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2016\/09\/2016-09-20-employee-earnings.png?w=525&#038;ssl=1\" \/><\/p>\n<p>Technicals, on the other hand, remain reasonably strong for the present. Until declining sales impact on corporate earnings. <\/p>\n<p>Source: <a href=\"http:\/\/www.nuveen.com\/Commentary\/BobDoll\/WeeklyCommentary.aspx?utm_source=WeeklyCommentary&amp;utm_medium=email&amp;utm_campaign=bobdoll&amp;spMailingID=9541399&amp;spUserID=MTI4MDMxOTQ0MTE5S0&amp;spJobID=1001569117&amp;spReportId=MTAwMTU2OTExNwS2\">Weekly Investment Commentary from Bob Doll | Nuveen<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>From Bob Doll&#8217;s weekly newsletter: The strong patch of summer U.S. economic data may have ended. Following weak Institute for Supply Management readings in previous weeks, August retail sales declined 0.3%. This marks the first pullback since March, and bears watching for a broader downtrend into September&#8230;.. Corporate earnings expectations are climbing slowly. Following a &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/thepatientinvestor.com\/index.php\/2016\/09\/19\/bob-doll-equities-appear-more-attractive-than-other-asset-classes-nuveen\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Bob Doll: Equities Appear More Attractive than Other Asset Classes | Nuveen&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_mo_disable_npp":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[5,57,34],"tags":[],"class_list":["post-14196","post","type-post","status-publish","format-standard","hentry","category-economy","category-stock-markets","category-us-canada-countries-regions"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Bob Doll: Equities Appear More Attractive than Other Asset Classes | Nuveen - the patient investor<\/title>\n<meta name=\"robots\" content=\"noindex, follow\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bob Doll: Equities Appear More Attractive than Other Asset Classes | Nuveen - the patient investor\" \/>\n<meta property=\"og:description\" content=\"From Bob Doll&#8217;s weekly newsletter: The strong patch of summer U.S. economic data may have ended. Following weak Institute for Supply Management readings in previous weeks, August retail sales declined 0.3%. This marks the first pullback since March, and bears watching for a broader downtrend into September&#8230;.. Corporate earnings expectations are climbing slowly. Following a &hellip; Continue reading &quot;Bob Doll: Equities Appear More Attractive than Other Asset Classes | Nuveen&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/thepatientinvestor.com\/index.php\/2016\/09\/19\/bob-doll-equities-appear-more-attractive-than-other-asset-classes-nuveen\/\" \/>\n<meta property=\"og:site_name\" content=\"the patient investor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61572934660810\" \/>\n<meta property=\"article:published_time\" content=\"2016-09-19T23:24:45+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/thepatientinvestor.com\/wp-content\/uploads\/2016\/09\/2016-09-20-retail.png\" \/>\n<meta name=\"author\" content=\"ColinTwiggs\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"ColinTwiggs\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2016\/09\/19\/bob-doll-equities-appear-more-attractive-than-other-asset-classes-nuveen\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2016\/09\/19\/bob-doll-equities-appear-more-attractive-than-other-asset-classes-nuveen\/\"},\"author\":{\"name\":\"ColinTwiggs\",\"@id\":\"https:\/\/thepatientinvestor.com\/#\/schema\/person\/cb072791ac83e8bae585007c133d54a5\"},\"headline\":\"Bob Doll: Equities Appear More Attractive than Other Asset Classes | Nuveen\",\"datePublished\":\"2016-09-19T23:24:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2016\/09\/19\/bob-doll-equities-appear-more-attractive-than-other-asset-classes-nuveen\/\"},\"wordCount\":254,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/thepatientinvestor.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2016\/09\/19\/bob-doll-equities-appear-more-attractive-than-other-asset-classes-nuveen\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/thepatientinvestor.com\/wp-content\/uploads\/2016\/09\/2016-09-20-retail.png\",\"articleSection\":[\"Economy\",\"Stock Markets\",\"US &amp; Canada\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/thepatientinvestor.com\/index.php\/2016\/09\/19\/bob-doll-equities-appear-more-attractive-than-other-asset-classes-nuveen\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2016\/09\/19\/bob-doll-equities-appear-more-attractive-than-other-asset-classes-nuveen\/\",\"url\":\"https:\/\/thepatientinvestor.com\/index.php\/2016\/09\/19\/bob-doll-equities-appear-more-attractive-than-other-asset-classes-nuveen\/\",\"name\":\"Bob Doll: Equities Appear More Attractive than Other Asset Classes | Nuveen - the patient investor\",\"isPartOf\":{\"@id\":\"https:\/\/thepatientinvestor.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2016\/09\/19\/bob-doll-equities-appear-more-attractive-than-other-asset-classes-nuveen\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2016\/09\/19\/bob-doll-equities-appear-more-attractive-than-other-asset-classes-nuveen\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/thepatientinvestor.com\/wp-content\/uploads\/2016\/09\/2016-09-20-retail.png\",\"datePublished\":\"2016-09-19T23:24:45+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2016\/09\/19\/bob-doll-equities-appear-more-attractive-than-other-asset-classes-nuveen\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/thepatientinvestor.com\/index.php\/2016\/09\/19\/bob-doll-equities-appear-more-attractive-than-other-asset-classes-nuveen\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2016\/09\/19\/bob-doll-equities-appear-more-attractive-than-other-asset-classes-nuveen\/#primaryimage\",\"url\":\"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2016\/09\/2016-09-20-retail.png?fit=4672%2C1800&ssl=1\",\"contentUrl\":\"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2016\/09\/2016-09-20-retail.png?fit=4672%2C1800&ssl=1\",\"width\":4672,\"height\":1800},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/thepatientinvestor.com\/index.php\/2016\/09\/19\/bob-doll-equities-appear-more-attractive-than-other-asset-classes-nuveen\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/thepatientinvestor.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bob Doll: Equities Appear More Attractive than Other Asset Classes | Nuveen\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/thepatientinvestor.com\/#website\",\"url\":\"https:\/\/thepatientinvestor.com\/\",\"name\":\"The Patient Investor\",\"description\":\"Smart. Strategic. Unfiltered. \",\"publisher\":{\"@id\":\"https:\/\/thepatientinvestor.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/thepatientinvestor.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/thepatientinvestor.com\/#organization\",\"name\":\"The Patient Investor Pty Ltd\",\"url\":\"https:\/\/thepatientinvestor.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1\",\"contentUrl\":\"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1\",\"width\":250,\"height\":250,\"caption\":\"The Patient Investor Pty Ltd\"},\"image\":{\"@id\":\"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/profile.php?id=61572934660810\",\"https:\/\/www.instagram.com\/colin_thepatientinvestor\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/thepatientinvestor.com\/#\/schema\/person\/cb072791ac83e8bae585007c133d54a5\",\"name\":\"ColinTwiggs\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g\",\"caption\":\"ColinTwiggs\"},\"url\":\"https:\/\/thepatientinvestor.com\/index.php\/author\/colin58s\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bob Doll: Equities Appear More Attractive than Other Asset Classes | Nuveen - the patient investor","robots":{"index":"noindex","follow":"follow"},"og_locale":"en_US","og_type":"article","og_title":"Bob Doll: Equities Appear More Attractive than Other Asset Classes | Nuveen - the patient investor","og_description":"From Bob Doll&#8217;s weekly newsletter: The strong patch of summer U.S. economic data may have ended. Following weak Institute for Supply Management readings in previous weeks, August retail sales declined 0.3%. This marks the first pullback since March, and bears watching for a broader downtrend into September&#8230;.. Corporate earnings expectations are climbing slowly. Following a &hellip; Continue reading \"Bob Doll: Equities Appear More Attractive than Other Asset Classes | Nuveen\"","og_url":"https:\/\/thepatientinvestor.com\/index.php\/2016\/09\/19\/bob-doll-equities-appear-more-attractive-than-other-asset-classes-nuveen\/","og_site_name":"the patient investor","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61572934660810","article_published_time":"2016-09-19T23:24:45+00:00","og_image":[{"url":"http:\/\/thepatientinvestor.com\/wp-content\/uploads\/2016\/09\/2016-09-20-retail.png","type":"","width":"","height":""}],"author":"ColinTwiggs","twitter_card":"summary_large_image","twitter_misc":{"Written by":"ColinTwiggs","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/thepatientinvestor.com\/index.php\/2016\/09\/19\/bob-doll-equities-appear-more-attractive-than-other-asset-classes-nuveen\/#article","isPartOf":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2016\/09\/19\/bob-doll-equities-appear-more-attractive-than-other-asset-classes-nuveen\/"},"author":{"name":"ColinTwiggs","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/person\/cb072791ac83e8bae585007c133d54a5"},"headline":"Bob Doll: Equities Appear More Attractive than Other Asset Classes | Nuveen","datePublished":"2016-09-19T23:24:45+00:00","mainEntityOfPage":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2016\/09\/19\/bob-doll-equities-appear-more-attractive-than-other-asset-classes-nuveen\/"},"wordCount":254,"commentCount":0,"publisher":{"@id":"https:\/\/thepatientinvestor.com\/#organization"},"image":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2016\/09\/19\/bob-doll-equities-appear-more-attractive-than-other-asset-classes-nuveen\/#primaryimage"},"thumbnailUrl":"https:\/\/thepatientinvestor.com\/wp-content\/uploads\/2016\/09\/2016-09-20-retail.png","articleSection":["Economy","Stock Markets","US &amp; Canada"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/thepatientinvestor.com\/index.php\/2016\/09\/19\/bob-doll-equities-appear-more-attractive-than-other-asset-classes-nuveen\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/thepatientinvestor.com\/index.php\/2016\/09\/19\/bob-doll-equities-appear-more-attractive-than-other-asset-classes-nuveen\/","url":"https:\/\/thepatientinvestor.com\/index.php\/2016\/09\/19\/bob-doll-equities-appear-more-attractive-than-other-asset-classes-nuveen\/","name":"Bob Doll: Equities Appear More Attractive than Other Asset Classes | Nuveen - the patient investor","isPartOf":{"@id":"https:\/\/thepatientinvestor.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2016\/09\/19\/bob-doll-equities-appear-more-attractive-than-other-asset-classes-nuveen\/#primaryimage"},"image":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2016\/09\/19\/bob-doll-equities-appear-more-attractive-than-other-asset-classes-nuveen\/#primaryimage"},"thumbnailUrl":"https:\/\/thepatientinvestor.com\/wp-content\/uploads\/2016\/09\/2016-09-20-retail.png","datePublished":"2016-09-19T23:24:45+00:00","breadcrumb":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2016\/09\/19\/bob-doll-equities-appear-more-attractive-than-other-asset-classes-nuveen\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/thepatientinvestor.com\/index.php\/2016\/09\/19\/bob-doll-equities-appear-more-attractive-than-other-asset-classes-nuveen\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thepatientinvestor.com\/index.php\/2016\/09\/19\/bob-doll-equities-appear-more-attractive-than-other-asset-classes-nuveen\/#primaryimage","url":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2016\/09\/2016-09-20-retail.png?fit=4672%2C1800&ssl=1","contentUrl":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2016\/09\/2016-09-20-retail.png?fit=4672%2C1800&ssl=1","width":4672,"height":1800},{"@type":"BreadcrumbList","@id":"https:\/\/thepatientinvestor.com\/index.php\/2016\/09\/19\/bob-doll-equities-appear-more-attractive-than-other-asset-classes-nuveen\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/thepatientinvestor.com\/"},{"@type":"ListItem","position":2,"name":"Bob Doll: Equities Appear More Attractive than Other Asset Classes | Nuveen"}]},{"@type":"WebSite","@id":"https:\/\/thepatientinvestor.com\/#website","url":"https:\/\/thepatientinvestor.com\/","name":"The Patient Investor","description":"Smart. Strategic. Unfiltered. ","publisher":{"@id":"https:\/\/thepatientinvestor.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/thepatientinvestor.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/thepatientinvestor.com\/#organization","name":"The Patient Investor Pty Ltd","url":"https:\/\/thepatientinvestor.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/","url":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1","contentUrl":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1","width":250,"height":250,"caption":"The Patient Investor Pty Ltd"},"image":{"@id":"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61572934660810","https:\/\/www.instagram.com\/colin_thepatientinvestor"]},{"@type":"Person","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/person\/cb072791ac83e8bae585007c133d54a5","name":"ColinTwiggs","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g","caption":"ColinTwiggs"},"url":"https:\/\/thepatientinvestor.com\/index.php\/author\/colin58s\/"}]}},"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p9tQ4n-3GY","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":14360,"url":"https:\/\/thepatientinvestor.com\/index.php\/2016\/10\/17\/weekly-investment-commentary-from-bob-doll-nuveen\/","url_meta":{"origin":14196,"position":0},"title":"Weekly Investment Commentary from Bob Doll | Nuveen","author":"ColinTwiggs","date":"October 17, 2016","format":false,"excerpt":"From Bob Doll: Equities may struggle until corporate earnings improve. For the past 18 months, equities have been able to make modest gains despite declining corporate profits. This has largely been due to highly accommodative monetary policy and central banks\u2019 willingness to engage in new easing measures. Additionally, investors have\u2026","rel":"","context":"In &quot;Stock Markets&quot;","block_context":{"text":"Stock Markets","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/stock-markets\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":14851,"url":"https:\/\/thepatientinvestor.com\/index.php\/2017\/02\/21\/we-are-growing-less-positive-but-not-negative-toward-equities-bob-doll\/","url_meta":{"origin":14196,"position":1},"title":"We Are Growing Less Positive (But Not Negative) Toward Equities | Bob Doll","author":"ColinTwiggs","date":"February 21, 2017","format":false,"excerpt":"Great headline from Bob Doll (Nuveen Investments) latest newsletter. \"....we think the easy gains for equities are in the rearview mirror and we are growing less positive toward the stock market. We do not believe the current bull market has ended, but the pace and magnitude of the gains we\u2026","rel":"","context":"In &quot;Stock Markets&quot;","block_context":{"text":"Stock Markets","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/stock-markets\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":14952,"url":"https:\/\/thepatientinvestor.com\/index.php\/2017\/03\/14\/equities-could-see-a-setback-but-this-bull-market-isnt-over-bob-doll\/","url_meta":{"origin":14196,"position":2},"title":"Equities Could See a Setback, But This Bull Market Isn\u2019t Over | Bob Doll","author":"ColinTwiggs","date":"March 14, 2017","format":false,"excerpt":"Sensible view from Bob Doll at Nuveen: ....Given evidence of stronger economic growth, we could see the Fed become slightly more aggressive about its rate policies, but probably not to the point that it would derail the equity bull market. On balance, we think the risks are skewed to the\u2026","rel":"","context":"In &quot;Banks &amp; Interest Rates&quot;","block_context":{"text":"Banks &amp; Interest Rates","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/economy\/the-fed-banks-interest-rates\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":16569,"url":"https:\/\/thepatientinvestor.com\/index.php\/2018\/07\/09\/bull-market-will-continue-at-least-for-now-bob-doll\/","url_meta":{"origin":14196,"position":3},"title":"Bull market will continue &#8211; at least for now | Bob Doll","author":"Colin Twiggs","date":"July 9, 2018","format":"quote","excerpt":"At some point in the coming months, we think it is more likely than not that equities will break out of their trading range to the upside and post new highs. Bob Doll - Weekly Commentary July 09, 2018","rel":"","context":"In &quot;Stock Markets&quot;","block_context":{"text":"Stock Markets","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/stock-markets\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":15617,"url":"https:\/\/thepatientinvestor.com\/index.php\/2017\/07\/21\/weekly-top-themes-from-bob-doll-nuveen\/","url_meta":{"origin":14196,"position":4},"title":"Weekly Top Themes from Bob Doll | Nuveen","author":"ColinTwiggs","date":"July 21, 2017","format":false,"excerpt":"U.S. monetary policy should remain equity-market friendly. In her comments last week, Janet Yellen stated that the neutral rate for the fed funds rate is \u201ccurrently quite low,\u201d and rates would not have to rise much more to become neutral. In our view, a neutral fed funds rate is closer\u2026","rel":"","context":"In &quot;Banks &amp; Interest Rates&quot;","block_context":{"text":"Banks &amp; Interest Rates","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/economy\/the-fed-banks-interest-rates\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":14017,"url":"https:\/\/thepatientinvestor.com\/index.php\/2016\/08\/22\/us-equity-prices-bob-doll\/","url_meta":{"origin":14196,"position":5},"title":"US equity prices | Bob Doll","author":"ColinTwiggs","date":"August 22, 2016","format":false,"excerpt":"Bob Doll's view on equities: Equity indices have again hit new records, but we believe fundamental changes may be necessary for prices to continue advancing strongly. Specifically, earnings would have to improve further and\/or investor flows would have to turn notably toward stocks. Neither is out of the question, but\u2026","rel":"","context":"In &quot;Stock Markets&quot;","block_context":{"text":"Stock Markets","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/stock-markets\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"_links":{"self":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts\/14196","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/comments?post=14196"}],"version-history":[{"count":0,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts\/14196\/revisions"}],"wp:attachment":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/media?parent=14196"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/categories?post=14196"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/tags?post=14196"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}